These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1849533)

  • 1. Role of Na+,K(+)-ATPase in the centrally mediated hypotensive effects of potassium in anaesthetized rats.
    Shah J; Jandhyala BS
    J Hypertens; 1991 Feb; 9(2):167-70. PubMed ID: 1849533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism by endothelin of centrally mediated cardiovascular effects of potassium in anaesthetized rats.
    Shah J; Jandhyala BS
    Clin Exp Pharmacol Physiol; 1992 Feb; 19(2):89-94. PubMed ID: 1555328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological significance of Na+/K(+)-ATPase activity in the central nervous system and endogenous sodium-pump inhibitors in the neural regulation of arterial blood pressure.
    Shah J; Jandhyala BS
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S13-5. PubMed ID: 7508016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent alterations in Na+, K(+)-ATPase activity in the central nervous system of spontaneously hypertensive rats: relationship to the development of high blood pressure.
    Shah J; Jandhyala BS
    Clin Exp Hypertens; 1995 Jul; 17(5):751-67. PubMed ID: 7655446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central hypertensive effect of ouabain in rats.
    Jacomini LC; Elghozi JL; Dagher G; Devynck MA; Meyer P
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):310-8. PubMed ID: 6324706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpolar amino acid substitutions of potential cation binding residues glu-955 and glu-956 of the rat alpha 1 isoform of Na+, K(+)-ATPase.
    Van Huysse JW; Lingrel JB
    Cell Mol Biol Res; 1993; 39(5):497-507. PubMed ID: 8173592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the role of sodium-potassium-activated ATPase as determinant of vascular reactivity in Wistar-Kyoto and spontaneously hypertensive rats.
    Göthberg G; Jandhyala B; Folkow B
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():187s-189s. PubMed ID: 6256113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of central dopamine receptors in the hypotensive action of pergolide.
    Jadhav AL; Willett RN; Sapru HN; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):281-6. PubMed ID: 6664381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of canrenone on blood pressure in rats with reduced renal mass.
    Pamnani MB; Whitehorn WV; Clough DL; Haddy FJ
    Am J Hypertens; 1990 Mar; 3(3):188-95. PubMed ID: 2157466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracisternal administration of pergolide, a dopamine receptor agonist, triggers the release of an inhibitor of ouabain-sensitive sodium, potassium-dependent adenosine triphosphatase and enhances vascular reactivity in anaesthetized dogs.
    Jandhyala BS; Lokhandwala MF; Kivlighn SD; Ansari AF; De Feo ML
    Clin Sci (Lond); 1987 Aug; 73(2):183-8. PubMed ID: 2443297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Na,K-ATPase in regulating acidification of early rat liver endocytic vesicles.
    Anbari M; Root KV; Van Dyke RW
    Hepatology; 1994 Apr; 19(4):1034-43. PubMed ID: 7511127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
    Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Na(+)/K (+)-ATPase parallels the increase in sodium transport and potassium recycling in an in vitro model of proximal tubule cellular ageing.
    Silva E; Gomes P; Soares-da-Silva P
    J Membr Biol; 2006; 212(3):163-75. PubMed ID: 17334838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In ability of Na+,K+-ATPase inhibitor to cause hypertension in sodium-loaded or deoxycorticosterone-treated one kidney rats.
    Nirasawa Y; Temma K; Fink GD; Akera T
    Life Sci; 1985 Aug; 37(8):767-74. PubMed ID: 2991692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANG-(3-4) inhibits renal Na+-ATPase in hypertensive rats through a mechanism that involves dissociation of ANG II receptors, heterodimers, and PKA.
    Dias J; Ferrão FM; Axelband F; Carmona AK; Lara LS; Vieyra A
    Am J Physiol Renal Physiol; 2014 Apr; 306(8):F855-63. PubMed ID: 24523384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of Na-K-ATPase to acute changes in renal tubular sodium and potassium transport.
    Katz AI; Lindheimer MD
    J Gen Physiol; 1975 Aug; 66(2):209-22. PubMed ID: 126301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrally-induced vasopressor responses to sodium-potassium adenosine triphosphatase inhibitor, ouabain, may be mediated via angiotensin II in the anteroventral third ventricle in the brain.
    Takahashi H; Iyoda I; Takeda K; Sasaki S; Okajima H; Yamasaki H; Yoshimura M; Ijichi H
    Jpn Circ J; 1984 Nov; 48(11):1243-50. PubMed ID: 6094853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transmembrane potential and electrogenicity of thrombocyte Na, K-ATPase in different forms of hypertension in rats].
    Kravtsov GM; Postnova NA; Postnov IuV
    Biull Eksp Biol Med; 1985 Aug; 100(8):174-6. PubMed ID: 2992629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade.
    Kramer HJ; Glänzer K; Freitag T; Schönfeld J; Sorger M; Schlebusch H; Düsing R; Krück F
    Klin Wochenschr; 1985 Jan; 63(1):32-6. PubMed ID: 2579261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.